abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', 'merck', 'astrazeneca', '$azn']
astrazeneca and merck present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium $azn 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks